English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
David Beasley | Jun 26, 2020

Emergency room visits for strokes, heart attacks declined after COVID-19 crisis, study finds

Press release submission | Jun 21, 2020

REISTONE: Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata

Press release submission | Jun 14, 2020

CANO HEALTH: Advises Patients Of Potential Data Security Issue

Bob Pepalis | Jun 3, 2020

Flawed data puts COVID-19 policies, treatments in doubt

Karen Kidd | Jun 1, 2020

Pandemic expands health care divide between red, blue states, LA Times reports

Press release submission | May 24, 2020

SYNDAX PHARMACEUTICALS: ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer

Press release submission | May 15, 2020

AMERICAN UROLOGICAL ASSOCIATION: Studies Highlight Barriers to and Disparities in Access to Care for Patients with Prostate Disease

Bob Pepalis | Apr 28, 2020

Political science professor calls Mexico's president 'reckless gambler' with COVID-19

Trending

+ Pharmaceuticals
Patient Daily | Oct 23, 2025

Empower seeks dismissal of Eli Lilly suit in Texas federal court

Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues

+ Pharmaceuticals
Patient Daily | Oct 29, 2025

Paragon Health Institute senior fellow: 340B program 'needs real reform'

Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'

  • « First
  • «
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily